<DOC>
	<DOCNO>NCT01207037</DOCNO>
	<brief_summary>Acute splenic sequestration frequent life threaten complication occur approximately 10 % homozygous child . Maximal incidence 6 18 month . The investigator formulate hypothesis clinical , biological genetic marker predictive severe complication notably acute splenic sequestration SCD child . The present research project thus aim analyze forward-looking way profile severity analyse clinical , biological genetic characteristic multicentric cohort 60 SCD child</brief_summary>
	<brief_title>Prognostic Factors Acute Splenic Sequestration</brief_title>
	<detailed_description>A prospective multicentric analysis conduct cohort 150 SS S ß ° child diagnose birth , include 3 -5 month follow age 24 month . Five visit , superimpose usual follow-up SCD child , ( Recommendations High Authority Health ) 3 month , 6 month , 12 month , 18 month 24 month allow clinical evaluation additional sampling blood ( 5 mL ) visit . The sample allow 1.analysis red blood cell phenotype ( adhesion deformability ) densities 2. genetic profile 3.to establish cell bank , sera bank DNA bank , Spleen function cohort estimate spleen scintigraphy , couple blood marker ( pitted cell , Howell-Jolly body count )</detailed_description>
	<criteria>Inclusion criterion : Children age 3 6 month homozygous ( SS ) S beta° sickle cell disease diagnose neonatal screening With history acute splenic sequestration Signed parental consent Patient cover national insurance scheme CMU Exclusion criterion : Children SCD genotype Children congenital anatomical asplenia Children previous episode acute splenic sequestration Absence possible followup Simultaneous enrolment another biomedical research</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>